AU2001256773A1 - Regulation of mt1-mmp activity - Google Patents
Regulation of mt1-mmp activityInfo
- Publication number
- AU2001256773A1 AU2001256773A1 AU2001256773A AU5677301A AU2001256773A1 AU 2001256773 A1 AU2001256773 A1 AU 2001256773A1 AU 2001256773 A AU2001256773 A AU 2001256773A AU 5677301 A AU5677301 A AU 5677301A AU 2001256773 A1 AU2001256773 A1 AU 2001256773A1
- Authority
- AU
- Australia
- Prior art keywords
- regulation
- mmp activity
- mmp
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000011716 Matrix Metalloproteinase 14 Human genes 0.000 title 1
- 108010076557 Matrix Metalloproteinase 14 Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
- C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000147739 | 2000-05-19 | ||
| JP2000-147739 | 2000-05-19 | ||
| PCT/JP2001/004166 WO2001088131A1 (en) | 2000-05-19 | 2001-05-18 | Regulation of mt1-mmp activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001256773A1 true AU2001256773A1 (en) | 2001-11-26 |
Family
ID=18653884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001256773A Abandoned AU2001256773A1 (en) | 2000-05-19 | 2001-05-18 | Regulation of mt1-mmp activity |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20040120954A1 (ja) |
| EP (1) | EP1288297A4 (ja) |
| AU (1) | AU2001256773A1 (ja) |
| WO (1) | WO2001088131A1 (ja) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1197456B1 (de) | 2000-10-10 | 2004-07-28 | Grapha-Holding AG | Verfahren und Anordnung zur Herstellung gefalzter Druckerzeugnisse |
| WO2004072639A1 (de) * | 2002-05-29 | 2004-08-26 | Helmut Ponta | Verfahren zur identifizierung von verbindungen zur unterdrückung metastasierender tumorzellen |
| JP2004175689A (ja) * | 2002-11-25 | 2004-06-24 | Kureha Chem Ind Co Ltd | 癌転移抑制剤 |
| US8722102B2 (en) * | 2010-01-29 | 2014-05-13 | Dechra Veterinary Products Llc | Compositions for treatment of skin and ear infections |
| US9133239B2 (en) | 2010-04-20 | 2015-09-15 | The Research Foundation For The State University Of New York | Compositions and methods for inhibiting matrix metalloproteinase (MMP)-mediated cell migration |
| CN102718840B (zh) * | 2012-08-06 | 2014-05-14 | 中山大学 | 一种人mmp-14抗原、相应单克隆抗体及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3802560B2 (ja) * | 1994-03-17 | 2006-07-26 | マックスデルブリュック−チェントラム フュール モレクラール メディツィン | マトリックス金属プロテアーゼのdna配列、その調製および使用 |
| GB9615976D0 (en) * | 1996-07-30 | 1996-09-11 | Center For Clinical & Basic Re | The use of proteinase inhibitors for the prevention or reduction of bone resorption |
-
2001
- 2001-05-18 EP EP01930205A patent/EP1288297A4/en not_active Withdrawn
- 2001-05-18 AU AU2001256773A patent/AU2001256773A1/en not_active Abandoned
- 2001-05-18 WO PCT/JP2001/004166 patent/WO2001088131A1/ja not_active Ceased
- 2001-05-18 US US10/276,272 patent/US20040120954A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001088131A1 (en) | 2001-11-22 |
| EP1288297A4 (en) | 2004-11-17 |
| EP1288297A1 (en) | 2003-03-05 |
| US20040120954A1 (en) | 2004-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001229712A1 (en) | Reduction of hair growth | |
| AU2002253836A1 (en) | Aptamer-mediated regulation of gene expression | |
| AU2002220082A1 (en) | Imaging of enzymatic activity | |
| AU2002234010A1 (en) | Benzamidine derivatives | |
| AU2001269123A1 (en) | Regulation of human dipeptidyl-peptidase iv-like enzyme | |
| AU2001263850A1 (en) | Pyrimidine-sulfonamides having endothelin-antagonist activity | |
| AU2001256773A1 (en) | Regulation of mt1-mmp activity | |
| AU2001281950A1 (en) | Regulation of human thimet oligopeptidase-like enzyme | |
| AU2002219992A1 (en) | Targeted regulation of gene expression | |
| AU2001274080A1 (en) | Regulation of human transketolase-like enzyme | |
| AU2001281939A1 (en) | Regulation of human alpha-hydroxysteroid dehydrogenase-like enzyme | |
| AU2001269095A1 (en) | Regulation of human caspase-1-like protease | |
| AU2002215942A1 (en) | Regulation of human carboxylesterase-like enzyme | |
| AU2002210525A1 (en) | Regulation of human phospholipase-like enzyme | |
| AU2001285782A1 (en) | Regulation of human phosphodiesterase-like enzyme | |
| AU2001281969A1 (en) | Regulation of human carboxylesterase-like enzyme | |
| AU2002221781A1 (en) | Regulation of human inositolpolyphosphate 5-phosphatase | |
| AU2001258330A1 (en) | New uses of imidazolylmethyl-pyridines | |
| AU2002215923A1 (en) | Use of medicaments | |
| AU2002212246A1 (en) | Regulation of human serine palmitoyltransferase-like enzyme | |
| AU2002216106A1 (en) | Regulation of human ubiquitin-conjugating enzyme e2 | |
| AU2001256350A1 (en) | Regulation of human lysostaphin-like protease | |
| AU5033101A (en) | Regulation of human heparanase-like enzyme | |
| AU3734901A (en) | Use of amidines | |
| AU3376501A (en) | Improvement of implantation rate |